VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
DMRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
DMRADamora Therapeutics, Inc.
$22.98$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDMRABalance Sheet

Damora Therapeutics, Inc. (DMRA) Balance Sheet

8Y historyFree accessUpdated daily

Damora Therapeutics, Inc. (DMRA) annual balance sheet — 8-year assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

DMRA Balance Sheet

Annual statement

DMRA Balance Sheet

Damora Therapeutics, Inc. (DMRA) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Total Current Assets531.32M260.42M16.84M36.77M63.91M110.1M169.29M56.08M34.96M
Cash & Short-Term Investments528.48M257.62M14.18M33.15M60.22M100.19M163.58M11.29M30.99M
Cash Only349.66M257.62M14.18M21.46M32.79M62.56M163.58M11.29M30.99M
Short-Term Investments178.82M0011.69M27.44M37.63M000
Accounts Receivable838K899K881K1.72M1.38M2.28M2.21M41.13M989K
Days Sales Outstanding---------
Inventory000000000
Days Inventory Outstanding---------
Other Current Assets469K1.32M1.19M1.13M1.5M5.9M1.86M3.66M2.98M
Total Non-Current Assets1.31M104K293K1.45M9.28M12.11M2.3M529K144K
Property, Plant & Equipment830K104K130K325K1.17M1.04M885K298K0
Fixed Asset Turnover0.00x--------
Goodwill000000000
Intangible Assets000000000
Long-Term Investments00005.83M9.05M254K231K144K
Other Non-Current Assets480K0163K1.13M2.28M2.03M1.16M00
Total Assets532.63M260.53M17.13M38.23M73.19M122.22M171.6M56.61M35.1M
Asset Turnover0.00x--------
Asset Growth %13537.41%1420.7%-55.18%-47.77%-40.12%-28.78%203.12%61.26%-
Total Current Liabilities35.89M20.07M1.2M5.83M11.11M4.54M5.57M7.93M4.44M
Accounts Payable6.08M444K377K1.7M3.35M1.53M2.85M3.33M1.41M
Days Payables Outstanding12.51K-760.25748.472.5K1.27K5.54K10.95K-
Short-Term Debt0012K183K476K399K374K87K0
Deferred Revenue (Current)000000000
Other Current Liabilities16.82M1.52M604K2.96M6.68M2.01M1.31M4.4M2.88M
Current Ratio14.80x12.98x14.07x6.31x5.75x24.23x30.42x7.07x7.87x
Quick Ratio14.80x12.98x14.07x6.31x5.75x24.23x30.42x7.07x7.87x
Cash Conversion Cycle---------
Total Non-Current Liabilities974K81K1.46M66K328K448K541K211K0
Long-Term Debt001.36M000000
Capital Lease Obligations999K53K61K66K328K448K541K211K0
Deferred Tax Liabilities000000000
Other Non-Current Liabilities28K28K43K000000
Total Liabilities36.87M20.15M2.66M5.9M11.44M4.99M6.11M8.14M4.44M
Total Debt1.1M68K1.43M249K804K847K915K298K0
Net Debt-348.56M-257.56M-12.74M-21.22M-31.98M-61.72M-162.67M-11M-30.99M
Debt / Equity0.00x0.00x0.10x0.01x0.01x0.01x0.01x0.01x-
Debt / EBITDA-0.00x--------
Net Debt / EBITDA1.15x--------
Interest Coverage---------4.35x
Total Equity495.76M240.38M14.47M32.33M61.75M117.22M165.49M48.47M30.66M
Equity Growth %18199.19%1561.12%-55.24%-47.64%-47.32%-29.17%241.42%58.09%-
Book Value per Share30.29176.3612.5130.4260.76116.01163.7747.6430.14
Total Shareholders' Equity495.76M240.38M14.47M32.33M61.75M117.22M165.49M48.47M30.66M
Common Stock1K00000000
Retained Earnings-578.31M-487.36M-277.52M-256.08M-217.74M-156.11M-104.36M-69.52M-33.02M
Treasury Stock000000000
Accumulated OCI-233K802K97K380K-244K-320K674K-2.45M-1.64M
Minority Interest000000000

DMRA — Frequently Asked Questions

Quick answers to the most common questions about buying DMRA stock.

What are the total assets of Damora Therapeutics, Inc. (DMRA)?

As of 2025, Damora Therapeutics, Inc. (DMRA) had total assets of $260.5M including $260.4M in current assets.

How much debt does Damora Therapeutics, Inc. (DMRA) have?

Damora Therapeutics, Inc. (DMRA) carries total debt of $0.1M, offset by $257.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Damora Therapeutics, Inc.?

Damora Therapeutics, Inc. (DMRA) has total shareholders' equity (book value) of $240.4M ($176.36 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Damora Therapeutics, Inc.'s current ratio and liquidity?

Damora Therapeutics, Inc. (DMRA) reported a current ratio of 12.98x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.